Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
NCT ID: NCT04518202
Last Updated: 2020-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2020-09-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
NCT04517890
Endocervical Lidocaine Spray for Pain Control During Office Hysteroscopy
NCT03382743
Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery
NCT03166111
Lidocaine In-situ Gel Before Intrauterine Device Insertion
NCT02943135
Lidocaine for Pain Control During Intrauterine Device Insertion
NCT03362905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lidocaine patch
5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.
lidocaine patch
5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.
Sham patch
Sham patch applied at 6 hours before the scheduled office hysteroscopy.
Sham patch
Sham patch containing no study medication applied at 6 hours before the scheduled office hysteroscopy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lidocaine patch
5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy.
Sham patch
Sham patch containing no study medication applied at 6 hours before the scheduled office hysteroscopy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* contraindication for lidocaine patch
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aswan University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hany farouk
A Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
nahla w Shady, md
Role: STUDY_CHAIR
Aswan universirty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aswan University Hospital
Aswān, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
aswu/296/3/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.